Moschos, S. J., Mooradian, M. J., Johnson, M. L., Opyrchal, M., Jänne, P. A., Romano, O., Brouwer, S., Sankoh, S., Ordentlich, P., Meyers, M. L., Betts, C., Sivagnanam, S., Coussens, L., Agarwala, S. S., Sullivan, R. J. (2026). Final results and correlative analysis of entinostat (E) plus pembrolizumab (P) in patients (Pts) with metastatic melanoma (MM) previously treated with anti–PD-(L)1 therapy (Tx).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9522